Location History:
- Hull, GB (2020 - 2021)
- Hull Humberside, GB (2022 - 2023)
Company Filing History:
Years Active: 2020-2023
Title: Mark Duncan Tarn: Innovator in Microfluidic Technologies
Introduction
Mark Duncan Tarn is a notable inventor based in Hull Humberside, GB. He has made significant contributions to the field of microfluidics, particularly in the analysis and preparation of radioactive substances. With a total of four patents to his name, Tarn's work is at the forefront of innovative technologies that have the potential to impact medical applications.
Latest Patents
Tarn's latest patents include a "Method for separation of radioactive sample using monolithic body on microfluidic chip." This invention relates to the use of monolithic bodies in the preparation of radioactive substances, such as radiopharmaceuticals, within a microfluidic flow system. Another significant patent is the "Method and apparatus for the analysis of compounds," which focuses on microfluidic devices and systems designed to determine sample characteristics. These inventions are particularly relevant for assessing the suitability of radiopharmaceuticals for patient administration.
Career Highlights
Mark Duncan Tarn is affiliated with the University of Hull, where he continues to advance research in microfluidic technologies. His work has garnered attention for its innovative approach to solving complex problems in the field of radiopharmaceuticals. Tarn's contributions are instrumental in enhancing the efficiency and effectiveness of medical treatments.
Collaborations
Tarn has collaborated with notable colleagues, including Stephen James Archibald and Nicole Pamme. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the realm of microfluidics.
Conclusion
Mark Duncan Tarn is a distinguished inventor whose work in microfluidic technologies is paving the way for advancements in medical applications. His patents reflect a commitment to innovation and a desire to improve the analysis and preparation of critical substances. Through his contributions, Tarn is making a significant impact in the field of medical research and technology.